Patient Controlled Injectors Market Size Set for Explosive Growth, With Projections Indicating $ 12.33 billion by 2031 | The Insight Partners | PR Newswire [Video]

The report from The Insight Partners lists several stakeholders—including healthcare providers, government agencies and health authorities, insurance providers, and academic and private research organizations—along with valuable insights on how to successfully navigate this evolving market landscape and unlock new opportunities.

NEW YORK, Dec. 13, 2024 /PRNewswire/ — According to a new comprehensive report from The Insight Partners, global patient controlled injectors market is expected to reach US$ 12.33 billion by 2031 from US$ 3.71 billion in 2021; it is anticipated to record a CAGR of 12.9% during the forecast period. Patient controlled injectors are medical devices that allow patients to administer their own medication, typically for pain management, by injecting a pre-measured dose. These devices offer a convenient and controlled administration, particularly in settings such as post-operative care or chronic pain conditions. The patient controlled injectors market is growing owing to the increasing prevalence of chronic diseases, along with the rising demand for …